{"title":"精神分裂症的利培酮反应:药物遗传学研究的叙述性回顾","authors":"J. Aneja","doi":"10.29245/2578-2959/2018/4.1161","DOIUrl":null,"url":null,"abstract":"Background: The response to risperidone in patients with schizophrenia is influenced by many factors including the genetic ones. The innovations in biotechnology have provided essential tools for conduction of pharmacogenetic research and subsequently a number of pharmaco-dynamic and pharmaco-kinetic studies delineating the response of anti-psychotics in schizophrenia have been conducted till date. So, we may prevision that pharmaco-genetic knowledge can provide us with the tools to personalize treatment in routine psychiatric clinical practice.","PeriodicalId":366333,"journal":{"name":"JOURNAL OF MENTAL HEALTH AND CLINICAL PSYCHOLOGY","volume":"31 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":"{\"title\":\"Risperidone Response in Schizophrenia: A Narrative Review of Pharmaco-Genetic Research\",\"authors\":\"J. Aneja\",\"doi\":\"10.29245/2578-2959/2018/4.1161\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: The response to risperidone in patients with schizophrenia is influenced by many factors including the genetic ones. The innovations in biotechnology have provided essential tools for conduction of pharmacogenetic research and subsequently a number of pharmaco-dynamic and pharmaco-kinetic studies delineating the response of anti-psychotics in schizophrenia have been conducted till date. So, we may prevision that pharmaco-genetic knowledge can provide us with the tools to personalize treatment in routine psychiatric clinical practice.\",\"PeriodicalId\":366333,\"journal\":{\"name\":\"JOURNAL OF MENTAL HEALTH AND CLINICAL PSYCHOLOGY\",\"volume\":\"31 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JOURNAL OF MENTAL HEALTH AND CLINICAL PSYCHOLOGY\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.29245/2578-2959/2018/4.1161\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JOURNAL OF MENTAL HEALTH AND CLINICAL PSYCHOLOGY","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29245/2578-2959/2018/4.1161","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Risperidone Response in Schizophrenia: A Narrative Review of Pharmaco-Genetic Research
Background: The response to risperidone in patients with schizophrenia is influenced by many factors including the genetic ones. The innovations in biotechnology have provided essential tools for conduction of pharmacogenetic research and subsequently a number of pharmaco-dynamic and pharmaco-kinetic studies delineating the response of anti-psychotics in schizophrenia have been conducted till date. So, we may prevision that pharmaco-genetic knowledge can provide us with the tools to personalize treatment in routine psychiatric clinical practice.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
